Thu, Dec 25, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Positive news for hedge funds says Lyxor research

Tuesday, January 22, 2013

Beverly Chandler, Opalesque London: Lyxor Asset Management’s latest research reveals that they have two key calls for 2013:

  • Risky assets outperform safe heavens
  • Hedge funds offer inviting risk-return profiles
The roots of their optimism can be traced to the realization of three scenarios, they write. "First, we expect a pickup of world activity, starting 1Q13, led by US and Asia. Second, we anticipate calming of political risks, following the recent non - US fiscal cliff - event, and the ongoing success of OMT measures in the euro-zone. Lastly, we believe that Central Banks should maintain ultra-loose monetary policies, as employment troubles take time to heal.

The firm argues that it’s time to prefer equities. "Equities remain historically cheap relative to safe haven bonds. Last year already saw the onset of normalization in equity risk premiums. We believe that risk premiums will ease again in 2013, as improving economic conditions prompt investors to become less and less reluctant to buy "risky" equities rather than "safe" government bonds".

In particular, Lyxor believes that European equities are well positioned. "Indeed, debt fears in peripheral countries sent domestic valuation metrics on ugly levels compared to their counterparts. European equities have room to significantly outperform U.S. equities in 2013. Moreover, the recent relaxation of Basel III rules should be a positive trigger for Eu......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its